No ‘RLD’ in the EEA [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2021-09-10 20:22 (336 d 14:26 ago) – Posting: # 22566
Views: 1,269

Hi Shahajan,

» […] I wanted to know if there will be no RLD available in EU region…

Lacking an ‘Orange Book’, there is no ‘Reference Listed Drug’ in the European Economic Area.
[image] = [image] [image] [image] [image] [image][image] [image] [image] [image] [image] [image] [image] [image] [image] [image] [image] [image] [image][image] [image] [image] [image] [image] [image] [image] [image] [image]
EEA = [image] + [image] [image] [image]
Read Ohlbe’s post again.

» …for a parenteral solution so how can we proceed for biowaiver for the particular parenteral product because for biowaiver we need to prove similarity between active substances as per GUIDELINE ON THE INVESTIGATION OF BIOEQUIVALENCE (CPMP/EWP/QWP/1401/98 Rev. 1/ Corr **) which states that: […]

Can you be more specific? ‘Parenteral’ is any route of administration which is not oral.
Only – given certain conditions – for aqueous intravenous solutions a biowaiver is possible.

» So how would we proceed in such cases?? shall we proceed with an available different dosage form of the same strength??

See above.

Dif-tor heh smusma 🖖 [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,301 posts in 4,667 threads, 1,585 registered users;
online 3 (0 registered, 3 guests [including 1 identified bots]).
Forum time: Saturday 10:48 CEST (Europe/Vienna)

In the field of observation,
chance favors only the mind that is prepared.    Louis Pasteur

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5